
Loading, please wait...

Loading, please wait...

Patients battling ovarian cancer often face a complex array of concurrent symptoms known as psychoneurological symptom clusters. These clusters typically include fatigue, insomnia, depression, and anxiety, which frequently manifest together rather than in isolation. Consequently, these symptoms can lead to treatment interruptions, reduced survival rates, and a significantly diminished quality of life. While conventional treatments focus on tumor reduction, effective management strategies for these interconnected symptoms remain limited. Therefore, researchers are investigating integrative protocols like the TiaoShenZhiAi (TSZA) regimen to provide a more holistic approach to symptom relief.
The TSZA regimen is an innovative intervention that combines traditional herbal medicine with modern psychological support. Specifically, the regimen utilizes Compound Ciwujia Granules, which contain Acanthopanax senticosus and Schisandra chinensis. These herbs are traditionally recognized for their adaptogenic and neuroprotective properties. Moreover, the protocol pairs this pharmacological approach with structured psychological intervention to address the emotional components of the symptom cluster. A multicenter, double-blind, randomized controlled trial is currently underway to evaluate the efficacy of this combined strategy against a low-dose active control.
The primary goal of this clinical trial is to determine the remission rate of psychoneurological symptom clusters at the three-month mark. In addition to primary outcomes, investigators are tracking secondary measures such as sleep quality, fatigue scales, and one-year survival rates. Furthermore, the study incorporates sophisticated exploratory indicators, including functional magnetic resonance imaging (fMRI) and biomarkers of the hypothalamic-pituitary-adrenal (HPA) axis. These biological markers will help clarify the underlying mechanisms by which the TSZA regimen influences the central nervous system and immune function. Eventually, this data may provide a blueprint for integrating traditional medicine into standard oncological care.
Effective management of symptom clusters requires a transition from treating single symptoms to addressing the synergy between psychological and neurological distress. Because traditional Chinese medicine often emphasizes systemic balance, it offers a unique framework for managing multi-symptom burdens. This study represents a rigorous attempt to validate such approaches through high-level clinical evidence. If successful, the TSZA regimen could become a standard supportive care option, helping patients maintain treatment adherence and improve their overall prognosis.
They are groups of three or more concurrent symptoms, such as pain, fatigue, and depression, that share a common underlying mechanism and impact patient outcomes more severely than individual symptoms.
It combines herbal granules (Acanthopanax and Schisandra) with psychological counseling to simultaneously target the biological and emotional drivers of cancer-related distress.
Many patients suffer from debilitating side effects that lead to treatment discontinuation. This trial seeks a safe, integrative way to stabilize these symptoms and improve long-term survival.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Liu Z et al. Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. JMIR Res Protoc. 2026 Jun 12. doi: 10.2196/88625. PMID: 42284089.
Huang J et al. Symptom Clusters in Ovarian Cancer Patients With Chemotherapy After Surgery: A Longitudinal Survey. Cancer Nurs. 2016;39(2):106-16.
Cazeau N. Understanding the Psychoneurological Symptom Cluster in Adults With Hematologic Malignancies. Oncology Nursing News. 2026.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Psychoneurological symptom clusters (PNSCs) significantly impair the quality of life for ovarian cancer patients. This study protocol evaluates the TiaoShenZhiAi (TSZA) regimen, an integrative approach combining herbal therapy and psychological intervention to improve patient outcomes and survival.
4 months ago

Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today

Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today